To study the effect of haridra siddha ghrita in the management of shushkakshipaka

Efficacy of haridra siddha ghrita in the management of shushkakshipaka with special reference to dry eye syndrome

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/01/023078

Enrollment

Registered

2020-01-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H00-H59- Diseases of the eye and adnexa

Interventions

Intervention1: haridra siddha ghrita in the anjana and internal dose 12gm: anjana application on lower eye lid And internal dose 12gm Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient of both sexes irrespective of the chronicity of the disease and ready for clinical trial.2.patient age between 20-50 years will be include 3. Patient having sign symptoms of Shushkakshipaka will be selected

Exclusion criteria

Exclusion criteria: B)EXCLUSIVE CRITERIA- 1. Patient age below 20 year and above 50 years. 2.Patient who are contraindicated for Anjana. 3.Patient with other ocular and symptomatic disease. 4.Corneal ulcer. 5.Congenital anamoly of eye 6..Patient with infective pathology of eye. 7..Severe case of dry eye syndrome. 8..Patient with lid globe opposition.

Design outcomes

Primary

Measure	Time frame
To observe the effect of haridrasidhaghrutapan and Anjana in Shushkaakshipaka.Timepoint: To observe the effect of haridrasidhaghrutapan and Anjana in Shushkaakshipaka.	—

Secondary

Measure	Time frame
To study the efficacy of haridra siddha ghrita in the management of shushkaakshipakaTimepoint: 6 months	—

Countries

India

Contacts

Public Contactdr Annasaheb patil

Reader

annapatil25@gmail.com9403456121

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026